Menu Close

Preclinical research: CAR T cell therapy effective against HER2-positive breast cancer with brain metastasis

Patients with HER2-positive breast cancer need more treatment options — today, it is estimated that about half of all women with HER2-positive breast cancer will eventually develop brain metastases, and current therapies for these patients are limited. (본문 전체 8/4/2018 8:10 AM)